View more job listings or post a job
Johnson & Johnson Scientist, DMPK, Biotransformation
Agios Pharmaceuticals Associate Director, DMPK/Clinical Pharmacology Agios is committed to applying our scientific leadership in cellular metabolism to transform the lives of patients with cancer and rare disease.</p
Pliant Therapeutics, Inc. DMPK, Senior Research Associate
Bristol Myers Squibb Sr Research Investigator for Redwood City, CA Location
Merck ADME Principal Scientist
ChemoCentryx Inc. Scientist (Scientist II, Senior Scientist or Principal Scientists) – Drug Metabolism, Pharmacokinetics & Clinical Pharmacology
Nektar Therapeutics Associate Director, Clinical Pharmacology
Genentech / Roche Contractor Scientific Researcher(SR)/Senior Scientific Researcher(SSR)– Mass Spectrometry
Genentech Scientific Researcher/Sr. Scientific Researcher, In Vitro DMPK/Mass Spectrometry
Genentech Scientific Researcher/Senior Scientific Researcher  in Purification Group Supporting Discovery Chemistry
Post a job


Preclinical development & IND Filing: Nuts, Bolts and Best Practices

Speakers: Tracy Chen, Jim Zhang, Peter Staehr, Anne Bonneville, Xingrong Liu
Organizers: Tracy Chen, Shichang Miao
Date: 1/22/2018
Time: 8:30-17:00
Registration fee (USD): Regular: $195; Academic: $125; For unemployed or students: $30; For major-sponsor rep (incl lunch): $0; For vendor-show rep: $35;
Location: SF Bay Area: Foster City Crowne Plaza
Major Sponsor: (2)Catalent Pharma Solutions; Medpace
Vendor show vendors registered to date: (22)Absorption Systems; Alcami; Applied StemCell Inc.; BioDuro; BRI Biopharmaceutical Research Inc.; Celerion; ChemPartner; Cyprotex; Cytovier LLC; Intertek; JOINN Labs; MicroConstants; Pacific BioLabs; PHARMout Laboratories; Pion Inc.; QPS; Quotient Clinical Ltd; Sekisui XenoTech, LLC; SOLVO Biotechnology; Spaulding Clinical Research; Worldwide Clinical Trials; WuXi AppTec
Registration deadline:1/22/2018  (it will close sooner if the seating cap is reached)

About the Topic

Investigational new drug (IND) application is an important milestone that marks the entry of a molecule into clinical development. Knowing the objectives, expectations, and processes of assembling and filing an IND is the key to not only a successful filing but also a promising clinical development path forward. Often, there are cases where too many nice-to-have studies crowd in the package but critical studies/issues are not addressed, and this can lead to significant delays in clinical development.  Additionally, the regulatory environment is changing as rapidly as the industry. Therefore, keeping up to date on the regulatory requirements and the industry’s best practices in different aspects including non-clinical safety, PK, CMC, and clinical plan is paramount. 

In this workshop, our speakers highly experienced with IND filings will discuss systemically the preclinical studies required for small molecule IND filings and the nuts, bolts, and best practices for putting together a high-quality IND package, as well as how to interact with various regulatory agencies.

The following topics will be covered:

- Overview of preclinical development and IND filing 
- Various preclinical studies required (Safety, DMPK & CMC)
- Clinical Development plans
- Interfacing with regulatory agencies including FDA


Workshop Agenda:

8:45-9:15   PBSS Welcome and Introduction (Tracy Chen)

9:15-10:30  1. Chemistry, Manufacturing, and Controls (Jim Zhang)

10:30-10:40  Major Sponsor’s Presentation (Medpace)

10:40-10:55  Break

10:55-12:25  2. NonClinical Pharmacology & Pharmacokinetics (Xingrong Liu)

12:25-1:25  Lunch

1:25-3:25  3. Toxicology in Drug Development (Anne Killam Bonneville)

3:25-3:45  Break

3:45-3:55  Major Sponsor’s Presentation (Catalent)

3:55-5:00  4. Clinical Development Plan and Interaction with FDA (Peter Staehr)

5:00-5:30  Panel Discussion (All Speakers)

2018-02-22, Metabolite Detection and Identification: Strategies, Techniques, and Case Studies
2018-03-12, Clinical Trials Essentials: An Intensive One-Week Course (register for the full week or half day sessions)
2018-04-24, Regulatory Authority Inspection Preparation and Outcomes
2018-05-22, Understanding and Overcoming High Clearance and Poor Bioavailability: Fundamentals, Investigations and Strategies for Drug Discovery
©Pharmaceutical & BioScience Society, International; Last Modified: 1/18/2018; Visited: 459519; Admin Logon
Ads (in random order)
Submit a Text Ad
($200 for 2 months)

Pacific BioLabs Offers toxicology,microbiology,analytical and bioanalytical services with a combination of technical expertise & rigorous quality systems.
Pharmaron Our Vision: To become the world-leading small-molecule life science R&D service company, supporting our partners from discovery to commercialization
Charles River 2nd Annual Viral Summit The 2-day summit unites industry experts in an interactive setting to share updates and discuss trends in viral safety and viral clearance.
Simulations Plus Are you ready to integrate in silico modeling & simulation to augment your research activities, but don’t have the time or resources? We can help!
Simulations Plus The new ADMET Predictor™ 8.1 provides #1-rated ADME-Tox predictions with improved performance for large libraries. Request an evaluation today!
Solid Form Solutions Ltd Solid Form Solutions Ltd CRO providing Solid State Crystallization and Analytical Testing Services to the pharma/biotech industries.
PHARMA INVENTOR Vancouver based Canadian Custom Synthesis Services Company, Offers Inventive & Cost-Effective Chemical Synthesis Services to Life Sciences Industries.
Nektar Therapeutics Sr. Scientist - Bioanalytical Contributes to the development, validation, and implementation of ligand-binding assays. PhD and 5 years exp.
Avecia Pharma Services Nitto Avecia Pharma provides GMP contract development and parenteral manufacturing services to the pharma/biotech industries. Visit our Irvine labs!
MicroConstants MicroConstants is a GLP-compliant Contract Research Organization focused on performing regulated bioanalysis, drug metabolism and PK analysis.
Pharm-Olam International Pharm-Olam is a midsize CRO offering a wide range of Phase I-IV comprehensive, clinical research services to the pharma, biotech & device industries.
Protein Characterization Seminar hosted by Charles River Join us in San Diego on September 15, 2017 to discuss the analytical methods used to detect process residuals and determine biosimilarity.
Simulations Plus GastroPlus™ PBPK modeling workshops scheduled around the globe to train scientists on the new guidance documents from the FDA and EMA. Register today!
Sirius Analytical Services and Automated Instruments for pKa, log P/D, solubility, dissolution. New Scissor instrument for sub-cutaneous injection site simulation.
INTERTEK PHARMACEUTICAL SERVICES Intertek, a bioanalytical CRO (drugs, biologics, proteins, ADCs, biosimilar, generics, peptide, biomarker, immunogenicity, ADA, Nab) in San Diego CA
Reaction Biology Corporation (RBC) RBC provides kinase & epigenetic assays and proteins for early-stage programs. Contact:
Simulations Plus GastroPlus™ developers launch PKPlus™. Generate validated PK reports for regulatory submissions. Value pricing/licensing. Request an evaluation today.
Clinverse Inc. A global technology company solely focused on automating the financial management of clinical trials.
Zef Scientific California’s premier multi-vendor LC-MS/MS engineering firm with highest level of services & rapid onsite response on all major brands & models.
S-Matrix Fusion QbD® Software – Analytical Method Development & Validation, Formulation & Process R&D. Works with ChemStation, Chromeleon, and Empower.
Nuventra Pharma Sciences With a background in clinical pharmacology and PK/PD, Nuventra enables our clients to make better strategic decisions.
Submit a Text Ad